Parkside Financial Bank & Trust’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4
Closed -$136 2099
2022
Q4
$136 Hold
4
﹤0.01% 1982
2022
Q3
$0 Sell
4
-58
-94% -$1.99K ﹤0.01% 1936
2022
Q2
$2K Buy
62
+34
+121% +$1.32K ﹤0.01% 1627
2022
Q1
$1K Hold
28
﹤0.01% 1773
2021
Q4
$1K Sell
28
-3
-10% -$151 ﹤0.01% 1757
2021
Q3
$2K Sell
31
-2
-6% -$111 ﹤0.01% 1601
2021
Q2
$2K Buy
33
+5
+18% +$274 ﹤0.01% 1575
2021
Q1
$2K Hold
28
﹤0.01% 1525
2020
Q4
$1K Buy
28
+18
+180% +$709 ﹤0.01% 1560
2020
Q3
$0 Hold
10
﹤0.01% 1643
2020
Q2
$0 Buy
+10
New +$379 ﹤0.01% 1678
2020
Q1
Sell
-18
Closed -$1K 1640
2019
Q4
$1K Hold
18
﹤0.01% 1471
2019
Q3
$1K Hold
18
﹤0.01% 1446
2019
Q2
$1K Sell
18
-8
-31% -$338 ﹤0.01% 1452
2019
Q1
$1K Buy
26
+11
+73% +$561 ﹤0.01% 1415
2018
Q4
$1K Hold
15
﹤0.01% 1316
2018
Q3
$1K Hold
15
﹤0.01% 1369
2018
Q2
$1K Hold
15
﹤0.01% 1360
2018
Q1
$1K Hold
15
﹤0.01% 1284
2017
Q4
$0 Hold
15
﹤0.01% 1485
2017
Q3
$0 Hold
15
﹤0.01% 1521
2017
Q2
$0 Hold
15
﹤0.01% 1532
2017
Q1
$0 Hold
15
﹤0.01% 1505
2016
Q4
$0 Buy
+15
New +$394 ﹤0.01% 1467

Other funds holding SRDX

Parkside Financial Bank & Trust's SRDX Position: Q1 2023 in Review

Parkside Financial Bank & Trust sold out of Surmodics (SRDX) in Q1 2023, closing a stake of 4 shares — an estimated $136 sold.

Parkside Financial Bank & Trust first reported a position in SRDX in Q4 2016 and held it in 24 quarters. The position peaked at $2K in Q2 2022. 119 funds tracked by Wall St. Rank hold SRDX as of Q1 2023.

  • Parkside Financial Bank & Trust reported no remaining Surmodics position as of Q1 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 4 Surmodics shares in Q1 2023, an estimated $136.
  • Parkside Financial Bank & Trust first reported a position in Surmodics in Q4 2016 and held it in 24 quarters.
  • Parkside Financial Bank & Trust's Surmodics position peaked at $2K in Q2 2022.
  • 119 funds tracked by Wall St. Rank held Surmodics as of Q1 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2023, filed 4 May 2023.